Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2004 4
2005 12
2006 13
2007 17
2008 14
2009 12
2010 12
2011 12
2012 12
2013 21
2014 13
2015 13
2016 13
2017 18
2018 17
2019 18
2020 8
Text availability
Article attribute
Article type
Publication date

Search Results

205 results
Results by year
Filters applied: . Clear all
Page 1
Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial.
Heerspink HJL, Parving HH, Andress DL, Bakris G, Correa-Rotter R, Hou FF, Kitzman DW, Kohan D, Makino H, McMurray JJV, Melnick JZ, Miller MG, Pergola PE, Perkovic V, Tobe S, Yi T, Wigderson M, de Zeeuw D; SONAR Committees and Investigators. Heerspink HJL, et al. Lancet. 2019 May 11;393(10184):1937-1947. doi: 10.1016/S0140-6736(19)30772-X. Epub 2019 Apr 14. Lancet. 2019. PMID: 30995972 Clinical Trial.
IDO decreases glycolysis and glutaminolysis by activating GCN2K, while it increases fatty acid oxidation by activating AhR, thus preserving CD4+ T‑cell survival and proliferation.
Eleftheriadis T, Pissas G, Liakopoulos V, Stefanidis I. Eleftheriadis T, et al. Among authors: Stefanidis I. Int J Mol Med. 2018 Jul;42(1):557-568. doi: 10.3892/ijmm.2018.3624. Epub 2018 Apr 16. Int J Mol Med. 2018. PMID: 29693118
Renal function in patients with non-dialysis chronic kidney disease receiving intravenous ferric carboxymaltose: an analysis of the randomized FIND-CKD trial.
Macdougall IC, Bock AH, Carrera F, Eckardt KU, Gaillard C, Van Wyck D, Meier Y, Larroque S, Roger SD; FIND-CKD Study investigators. Macdougall IC, et al. BMC Nephrol. 2017 Jan 17;18(1):24. doi: 10.1186/s12882-017-0444-6. BMC Nephrol. 2017. PMID: 28095881 Free PMC article. Clinical Trial.
Safety of intravenous ferric carboxymaltose versus oral iron in patients with nondialysis-dependent CKD: an analysis of the 1-year FIND-CKD trial.
Roger SD, Gaillard CA, Bock AH, Carrera F, Eckardt KU, Van Wyck DB, Cronin M, Meier Y, Larroque S, Macdougall IC; FIND-CKD Study Investigators. Roger SD, et al. Nephrol Dial Transplant. 2017 Sep 1;32(9):1530-1539. doi: 10.1093/ndt/gfw264. Nephrol Dial Transplant. 2017. PMID: 28339831 Free PMC article. Clinical Trial.
Uric acid and cellular and humoral alloimmunity.
Eleftheriadis T, Pissas G, Liakopoulos V, Stefanidis I. Eleftheriadis T, et al. Among authors: Stefanidis I. J Heart Lung Transplant. 2018 Nov;37(11):1388. doi: 10.1016/j.healun.2018.08.004. Epub 2018 Aug 8. J Heart Lung Transplant. 2018. PMID: 30241887 No abstract available.
Pancreatogastrostomy versus Pancreatojejunostomy: An Up-to-Date Meta-Analysis of RCTs.
Perivoliotis K, Sioka E, Tatsioni A, Stefanidis I, Zintzaras E, Zacharoulis D. Perivoliotis K, et al. Among authors: Stefanidis I. Int J Surg Oncol. 2017;2017:7526494. doi: 10.1155/2017/7526494. Epub 2017 Jul 17. Int J Surg Oncol. 2017. PMID: 28798875 Free PMC article. Review.
Bioabsorbable stenting in peripheral artery disease.
Galyfos G, Geropapas G, Stefanidis I, Kerasidis S, Stamatatos I, Kastrisios G, Giannakakis S, Papacharalampous G, Maltezos C. Galyfos G, et al. Among authors: Stefanidis I. Cardiovasc Revasc Med. 2015 Dec;16(8):480-3. doi: 10.1016/j.carrev.2015.08.005. Epub 2015 Aug 15. Cardiovasc Revasc Med. 2015. PMID: 26365606 Review.
205 results
Jump to page